DMTTF - Small Pharma - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

DMTTF is currently covered by 1 analysts

Small Pharma's activity chart (see below) currently has 0 price targets and 1 ratings on display. The stock rating distribution of DMTTF is 100% BUY.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from on 25-Apr-2024.

Best performing analysts who are covering DMTTF - Small Pharma:

Elemer Piros

Currently out of the existing stock ratings of DMTTF, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DMTTF (Small Pharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on DMTTF (Small Pharma) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on DMTTF (Small Pharma)?

Elemer Piros works at BENCHMARK and has 6 price targets and 6 ratings on DMTTF

Which analyst is the currently most bullish on DMTTF (Small Pharma)?

Elemer Piros with highest potential upside - $0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?